# Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

> **NCT00881413** · PHASE4 · WITHDRAWN · sponsor: **Lotung Poh-Ai Hospital**

## Conditions studied

- Peptic Ulcer

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT00881413
- **Lead sponsor:** Lotung Poh-Ai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** problems in funding
- **Last updated:** 2015-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00881413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00881413, "Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00881413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*